- Deltex Medical Group, the global leader in oesophageal Doppler monitoring, has added a further new account to its platform programme in the US.

The account is a major hospital in the Mid-West and is the first platform programme account in the Great Lakes sales territory which the Company established in the first quarter of 2015.

The hospital has committed to purchase at least 65 probes per month during its initial implementation phase.

Chief executive Ewan Phillips said: "The US is an increasingly important market for us and we are pleased to have this, the sixth account added to our US platform programme this year and the 12th in total. Deltex Medical is making good progress towards our current goal of 30 US hospitals on its platform programme by mid-2016."

At 8:39am: [LON:DEMG] Deltex Medical Group PLC share price was +0.13p at 5.5p

Story provided by